The effectiveness of Combined Treatment of Carboxytherapy and Platelet-Rich Plasma (PRP) Compared to Platelet-Rich Plasma Alone, in the Treatment of Women with Androgenic Hair Loss Treated with Anti-Androgen Drugs.

Comparison of The Efficacy of Platelet-Rich Plasma (PRP) Combined with Carboxytherapy vs PRP Monotherapy in Females with Androgenetic Alopecia Treated with Antiandrogen Drugs

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220919055994N2

Enrollment

Registered

2023-05-30

Start date

2023-06-21

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women without Previous Underlying Disease, Suffering from Androgenic Hair Loss. Cicatricial alopecia [scarring hair loss]

Interventions

All Patients are Randomly Divided (based on the table of Random Numbers) into two Groups Receiving PRP and Treated with PRP Combined with Carboxytherapy. For All Patients, the Use of Cyproterone Compo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Diagnosis of Androgenetic Alopecia

Exclusion criteria

Exclusion criteria: Platelet Disorders, Thrombocytopenia, Anemia, Cardio-Pulmonary Diseases, Kidney Disease, Vasovagal Syncope, Uncontrolled Blood Pressure, Use of Anticoagulant Drugs, Thyroid Dysfunction, Diabetes, Sepsis and Cancer.

Design outcomes

Primary

Measure	Time frame
Androgenic Hair Loss. Timepoint: Once a Month. Method of measurement: Physical Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Rastaghi

Kerman University of Medical Sciences

fatemeh_rastaghi@yahoo.com+98 34 3132 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026